Patent: 7,371,376
Summary for Patent: 7,371,376
| Title: | Anti-ErbB2 antibodies |
| Abstract: | Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described. |
| Inventor(s): | Brian M. Fendly |
| Assignee: | Genentech Inc |
| Application Number: | US09/705,579 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,371,376
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | PERJETA | pertuzumab | Injection | 125409 | June 8, 2012 | 7,371,376 | 2020-11-02 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
